Identification of an in vivo MEK/WOX1 complex as a master switch for apoptosis in t cell leukemia

Genes and Cancer

Volumn 2, Issue 5, 2011, Pages 550-562

  Lin, Hsin Ping ^a   Chang, Jean Yun ^a   Lin, Sing Ru ^a   Lee, Ming Hui ^a   Huang, Shenq Shyang ^a   Hsu, Li Jin ^a   Chang, Nan Shan ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

apoptosis; MEK; PMA; U0126; WOX1; WWOX

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WOX1 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL LINE; LYMPHOCYTE DIFFERENTIATION; LYSOSOME MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

EID: 80053012914     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911418498     Document Type: Article

References (54)

1. Germain RN.T-cell development and the CD4-CD8 lineage decision.Nat Rev Immunol. 2002;2:309-22.
2. Takahama Y.Journey through the thymus: stromal guides for T-cell development and selection.Nat Rev Immunol. 2006;6:127-35.
3. Hildeman DA,Zhu Y,Mitchell TC,Kappler J,Marrack P.Molecular mechanisms of activated T cell death in vivo.Curr Opin Immunol. 2002;14:354-9.
4. Goel G,Makkar HP,Francis G,Becker K.Phorbol esters: structure, biological activity, and toxicity in animals.Int J Toxicol. 2007;26:279-88.
5. Kang CD,Lee BK,Kim KW,Kim CM,Kim SH,Chung BS.Signaling mechanism of PMA-induced differentiation of K562 cells.Biochem Biophys Res Commun. 1996;221:95-100.
6. Westberg JA,Zhang KZ,Andersson LC.Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin.FASEB J. 1999;13:1621-6.
7. Drexler HG,Gaedicke G,Minowada J.T-leukemia cell lines CCRF-CEM, HPB-ALL, JM and MOLT-4: changes in isoenzyme profiles during induction of differentiation.Blut. 1987;54:79-87.
8. Nagasawa K,Mak TW.Phorbol esters induce differentiation in human malignant T lymphoblasts.Proc Natl Acad Sci U S A. 1980;77:2964-8.
9. Nakao Y,Matsuda S,Fujita T, et al.Phorbol ester-induced differentiation of human T-lymphoblastic cell line HPB-ALL.Cancer Res. 1982;42:3843-50.
10. Ryffel B,Henning CB,Huberman E.Differentiation of human T-lymphoid leukemia cells into cells that have a suppressor phenotype is induced by phorbol 12-myristate 13-acetate.Proc Natl Acad Sci U S A. 1982;79:7336-40.
11. Nagasawa K,Howatson A,Mak TW.Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.J Cell Physiol. 1981;109:181-92.
12. Lai JM,Wu S,Huang DY,Chang ZF.Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13-acetate-induced apoptotic cells.Mol Cell Biol. 2002;22:7581-92.
13. Bednarek AK,Laflin KJ,Daniel RL,Liao Q,Hawkins KA,Aldaz C.WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.Cancer Res. 2000;60:2140-5.
14. Ried K,Finnis M,Hobson L, et al.Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.Hum Mol Genet. 2000;9:1651-63.
15. Chang NS,Pratt N,Heath J, et al.Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.J Biol Chem. 2001;276:3361-70.
16. Chang NS,Hsu LJ,Lin YS,Lai FJ,Sheu HM.WW domain- containing oxidoreductase: a candidate tumor suppressor.Trends Mol Med. 2007;13:12-22.
17. Smith DI,McAvoy S,Zhu Y,Perez DS.Large common fragile site genes and cancer.Semin Cancer Biol. 2007;17:31-41.
18. Aqeilan RI,Croce CM.WWOX in biological control and tumorigenesis.J Cell Physiol. 2007;212:307-10.
19. Del Mare S,Salah Z,Aqeilan RI.WWOX: its genomics, partners, and functions.J Cell Biochem. 2009;108:737-45.
20. Chang JY,He RY,Lin HP, et al.Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase.Exp Biol Med. 2010;235:796-804.
21. Aqeilan RI,Trapasso F,Hussain S, et al.Targeted deletion of Wwox reveals a tumor suppressor function.Proc Natl Acad Sci U S A. 2007;104:3949-54.
22. Aqeilan RI,Hassan MQ,de Bruin A, et al.The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism.J Biol Chem. 2008;283:21629-39.
23. Ludes-Meyers JH,Kil H,Nunez MI, et al.WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.Genes Chromosomes Cancer. 2007;46:1129-36.
24. Chang NS,Doherty J,Ensign A,Schultz L,Hsu LJ,Hong Q.WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.J Biol Chem. 2005;280:43100-8.
25. Chang NS,Doherty J,Ensign A.JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.J Biol Chem. 2003;278:9195-202.
26. Mahajan NP,Whang YE,Mohler JL,Earp HS.Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.Cancer Res. 2005;65:10514-23.
27. Chang NS,Schultz L,Hsu LJ,Lewis J,Su M,Sze CI.17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.Oncogene. 2005;24:714-23.
28. Hsu LJ,Schultz L,Hong Q, et al.Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1.J Biol Chem. 2009;284:16049-59.
29. Hong Q,Sze CI,Lin SR, et al.Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.PLoS One. 2009;4:e5755.
30. Chen ST,Chuang JI,Cheng CL,Hsu LJ,Chang NS.Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo.Neuroscience. 2005;130:397-407.
31. Lo CP,Hsu LJ,Li MY, et al.MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.Eur J Neurosci. 2008;27:1634-46.
32. Li MY,Lai FJ,Hsu LJ, et al.Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats.PLoS One. 2009;4:e7820.
33. Minowada J,Onuma T,Moore GE.Rosette-forming human lymphoid cell lines: I. Establishment and evidence for origin of thymus-derived lymphocytes.J Natl Cancer Inst. 1972;49:891-5.
34. Burger R,Hansen-Hagge TE,Drexler HG,Gramatzki M.Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies.Leuk Res. 1999;23:19-27.
35. Griner EM,Kazanietz MG.Protein kinase C and other diacylglycerol effectors in cancer.Nat Rev Cancer. 2007;7:281-94.
36. Herrant M,Luciano F,Loubat A,Auberger P.The protective effect of phorbol esters on Fas-mediated apoptosis in T cells: transcriptional and postranscriptional regulation.Oncogene. 2002;21:4957-68.
37. Meng XW,Heldebrant MP,Kaufmann SH.Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain.J Biol Chem. 2002;277:3776-83.
38. Engedal N,Blomhoff HK.Combined action of ERK and NF kappa B mediates the protective effect of phorbol ester on Fas-induced apoptosis in Jurkat cells.J Biol Chem. 2003;278:10934-41.
39. Bond JA,Gescher AJ,Verschoyle RD, et al.Cytotoxic action of phorbol esters on human pancreatic cancer cells.Int J Cancer. 2007;121:1445-54.
40. Gonzalez-Guerrico AM,Meshki J,Xiao L,Benavides F,Conti CJ,Kazanietz MG.Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells.J Biochem Mol Biol. 2005;38:639-45.
41. Duncia JV,Santella JB,Higley CA, et al.MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.Bioorg Med Chem Lett. 1998;8:2839-44.
42. DeSilva DR,Jones EA,Favata MF, et al.Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy.J Immunol. 1998;160:4175-81.
43. Favata MF,Horiuchi KY,Manos EJ, et al.Identification of a novel inhibitor of mitogen-activated protein kinase kinase.J Biol Chem. 1998;273:18623-32.
44. Tait SW,Green DR.Caspase-independent cell death: leaving the set without the final cut.Oncogene. 2008;27:6452-61.
45. Van Herreweghe F,Festjens N,Declercq W,Vandenabeele P.Tumor necrosis factor-mediated cell death: to break or to burst, that's the question.Cell Mol Life Sci. 2010;67:1567-79.
46. Ohren JF,Chen H,Pavlovsky A, et al.Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.Nat Struct Mol Biol. 2004;11:1192-7.
47. Gaudio E,Palamarchuk A,Palumbo T, et al.Physical association with WWOX suppresses c-Jun transcriptional activity.Cancer Res. 2006;66:11585-9.
48. Schlesinger TK,Fanger GR,Yujiri T,Johnson GL.The TAO of MEKK.Front Biosci. 1998;3:D1181-6.
49. Widmann C,Gerwins P,Johnson NL,Jarpe MB,Johnson GL.MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis.Mol Cell Biol. 1998;18:2416-29.
50. Monje P,Hernandez-Losa J,Lyons RJ,Castellone MD,Gutkind JS.Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.J Biol Chem. 2005;280:35081-4.
51. Deffenbacher KE,Iqbal J,Liu Z,Fu K,Chan WC.Recurrent chromosomal alterations in molecularly classified AIDS-related lymphomas: an integrated analysis of DNA copy number and gene expression.J Acquir Immune Defic Syndr. 2010;54:18-26.
52. Capello D,Scandurra M,Poretti G, et al.Genome wide DNA-profiling of HIV-related B-cell lymphomas.Br J Haematol. 2010;148:245-55.
53. Julia F,Thomas L,Dumontet C,Dalle S.Targeted therapies in metastatic melanoma: toward a clinical breakthrough?.Anticancer Agents Med Chem. 2010;10:661-5.
54. Balagula Y,Barth Huston K,Busam KJ,Lacouture ME,Chapman PB,Myskowski PL.Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib.Invest New Drugs. 2010;:.